Literature DB >> 16374146

The metabolic syndrome: a call to action.

Antonio M Gotto1, George L Blackburn, George E Dailey, Alan J Garber, Scott M Grundy, Burton E Sobel, Matthew R Weir.   

Abstract

Metabolic syndrome, a cluster of risk factors that enhances the risk for atherosclerotic cardiovascular disease, has received increasing attention in recent years, especially as the worldwide prevalence of obesity has become better defined. Recent controversy has questioned the scientific basis for metabolic syndrome, but does not negate its value as a description of a common phenotype of patients encountered in clinical practice. Revised and refined diagnostic criteria may be useful for physicians. While more research is needed to understand the pathology of the metabolic syndrome, there is no ambiguity that physicians should treat cardiovascular risk factors in individuals with metabolic syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16374146     DOI: 10.1097/00019501-200602000-00013

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  14 in total

1.  A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response.

Authors:  Jonathon N Winnay; Jeremie Boucher; Marcelo A Mori; Kohjiro Ueki; C Ronald Kahn
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

2.  High-fructose diet initiated during adolescence does not affect basolateral amygdala excitability or affective-like behavior in Sprague Dawley rats.

Authors:  Brendan O'Flaherty; Gretchen N Neigh; Donald Rainnie
Journal:  Behav Brain Res       Date:  2019-02-23       Impact factor: 3.332

Review 3.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

4.  Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN study.

Authors:  G de Simone; D K Arnett; M Chinali; M De Marco; D C Rao; A T Kraja; S C Hunt; R B Devereux
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-05-12       Impact factor: 4.222

5.  Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

Authors:  J C Russell; S D Proctor
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 6.  Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.

Authors:  Samir Softic; David E Cohen; C Ronald Kahn
Journal:  Dig Dis Sci       Date:  2016-02-08       Impact factor: 3.199

7.  Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.

Authors:  G de Simone; R B Devereux; M Chinali; M J Roman; E T Lee; H E Resnick; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-07-31       Impact factor: 4.222

8.  Metabolic syndrome: a challenging health issue in highly urbanized Union Territory of north India.

Authors:  Chetna Mangat; N K Goel; Dinesh K Walia; Neeraj Agarwal; Munesh K Sharma; Jasbinder Kaur; Ram Singh; Gagandeep Singh
Journal:  Diabetol Metab Syndr       Date:  2010-03-23       Impact factor: 3.320

9.  Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.

Authors:  Samir Softic; Manoj K Gupta; Guo-Xiao Wang; Shiho Fujisaka; Brian T O'Neill; Tata Nageswara Rao; Jennifer Willoughby; Carole Harbison; Kevin Fitzgerald; Olga Ilkayeva; Christopher B Newgard; David E Cohen; C Ronald Kahn
Journal:  J Clin Invest       Date:  2017-10-03       Impact factor: 14.808

10.  LncRNA DLEU2 regulates sirtuins and mitochondrial respiratory chain complex IV: a novel pathway in obesity and offspring's health.

Authors:  Jian Zhang; Matthew Krivacka Kay; Min Hi Park; Sunitha Meruvu; Catherine Powell; Mahua Choudhury
Journal:  Int J Obes (Lond)       Date:  2022-01-20       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.